2017

  1. ABBADESSA, A., LANDÍN, M., OUDE BLENKE, E., HENNINK, W.E. and VERMONDEN, T., 2017. Two-component thermosensitive hydrogels: Phase separation affecting rheological behavior. European Polymer Journal, 92, pp. 13-26.
  2. ALAARG, A., PÉREZ-MEDINA, C., METSELAAR, J.M., NAHRENDORF, M., FAYAD, Z.A., STORM, G. and MULDER, W.J.M., 2017. Applying nanomedicine in maladaptive inflammation and angiogenesis. Advanced Drug Delivery Reviews, 119, pp. 143-158.
  3. ALAARG, A., SENDERS, M.L., VARELA-MOREIRA, A., PÉREZ-MEDINA, C., ZHAO, Y., TANG, J., FAY, F., REINER, T., FAYAD, Z.A., HENNINK, W.E., METSELAAR, J.M., MULDER, W.J.M. and STORM, G., 2017. A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis. Journal of Controlled Release, 262, pp. 47-57.
  4. ALLIJN, I.E., CZARNY, B.M.S., WANG, X., CHONG, S.Y., WEILER, M., DA SILVA, A.E., METSELAAR, J.M., LAM, C.S.P., PASTORIN, G., DE KLEIJN, D.P.V., STORM, G., WANG, J.-. and SCHIFFELERS, R.M., 2017. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. Journal of Controlled Release, 247, pp. 127-133.
  5. BAKHSHANDEH, S., GORGIN KARAJI, Z., LIETAERT, K., FLUIT, A.C., BOEL, C.H.E., VOGELY, H.C., VERMONDEN, T., HENNINK, W.E., WEINANS, H., ZADPOOR, A.A. and AMIN YAVARI, S., 2017. Simultaneous Delivery of Multiple Antibacterial Agents from Additively Manufactured Porous Biomaterials to Fully Eradicate Planktonic and Adherent Staphylococcus aureus. ACS Applied Materials and Interfaces, 9(31), pp. 25691-25699.
  6. BANSAL, R., Nakagawa, S., YAZDANI, S., VAN BAARLEN, J., VENKATESH, A., KOH, A.P., SONG, W.M., GOOSSENS, N., WATANABE, H., BEASLEY, M.B., POWELL, C.A., STORM, G., KAMINSKI, N., VAN GOOR, H., FRIEDMAN, S.L., HOSHIDA, Y. PRAKASH, J., 2017. Integrin alpha 11 in the regulation of the myofibroblast phenotype: implications for fibrotic diseases. Experimental & Molecular Medicine 49(11), pp. e396.
  7. BINNEMARS-POSTMA, K., STORM, G. and PRAKASH, J., 2017. Nanomedicine strategies to target tumor-associated macrophages. International Journal of Molecular Sciences, 18(5), pii: E979.
  8. Binnemars-Postma K, Bansal R, Storm G, Prakash J. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer. FASEB J. 2017 Oct 24. (in press).
  9. 10.1096/fj.201700629R.
  10. BUWALDA, S.J., VERMONDEN, T. and HENNINK, W.E., 2017. Hydrogels for Therapeutic Delivery: Current Developments and Future Directions. Biomacromolecules, 18(2), pp. 316-330.
  11. CAIAZZO, M., TABATA, Y. and LUTOLF, M., 2017. Generation of induced pluripotent stem cells in defined three-dimensional hydrogels.
  12. CASTILHO, M., FEYEN, D., FLANDES-IPARRAGUIRRE, M., HOCHLEITNER, G., GROLL, J., DOEVENDANS, P.A.F., VERMONDEN, T., ITO, K., SLUIJTER, J.P.G. and MALDA, J., 2017. Melt Electrospinning Writing of Poly-Hydroxymethylglycolide-co-ε-Caprolactone-Based Scaffolds for Cardiac Tissue Engineering. Advanced Healthcare Materials, 6(18), 6: 1700311
  13. CASTRO-NÚÑEZ, L., KOORNNEEF, J.M., RONDAIJ, M.G., BLOEM, E., VAN DER ZWAAN, C., MERTENS, K., MEIJER, A.B. and MEEMS, H., 2017. Cellular uptake of coagulation factor VIII: Elusive role of the membrane-binding spikes in the C1 domain. International Journal of Biochemistry and Cell Biology, 89, pp. 34-41.
  14. CHEN, W., CLAUSER, J., THIEBES, A.L., MCGRATH, D.J., KELLY, N., VAN STEENBERGEN, M.J., JOCKENHOEVEL, S., STEINSEIFER, U., MCHUGH, P.E., HENNINK, W.E. and KOK, R.J., 2017. Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating. European Journal of Pharmaceutical Sciences, 103, pp. 94-103.
  15. CHEN, W., DI CARLO, C., DEVERY, D., MCGRATH, D.J., MCHUGH, P.E., KLEINSTEINBERG, K., JOCKENHOEVEL, S., HENNINK, W.E. and KOK, R.J., 2017. Fabrication and characterization of gefitinib-releasing polyurethane foam as a coating for drug-eluting stent in the treatment of bronchotracheal cancer. International journal of pharmaceutics, (in press).
  16. CHEN, W., PALAZZO, A., HENNINK, W.E. and KOK, R.J., 2017. Effect of particle size on drug loading and release kinetics of gefitinib-loaded PLGA microspheres. Molecular Pharmaceutics, 14(2), pp. 459-467.
  17. CHEN, Y., DAKWAR, G.R., BRAECKMANS, K., LAMMERS, T., HENNINK, W.E. and METSELAAR, J.M., 2017. In Vitro Evaluation of Anti-Aggregation and Degradation Behavior of PEGylated Polymeric Nanogels under In Vivo Like Conditions. Macromolecular Bioscience, (in press).
  18. CHEN, Y., TEZCAN, O., LI, D., BEZTSINNA, N., LOU, B., ETRYCH, T., ULBRICH, K., METSELAAR, J.M., LAMMERS, T. and HENNINK, W.E., 2017. Overcoming multidrug resistance using folate receptor-targeted and pH-responsive polymeric nanogels containing covalently entrapped doxorubicin. Nanoscale, 9(29), pp. 10404-10419.
  19. DE NARDIS, C., LOSSL, P., VAN DEN BIGGELAAR, M., MADOORI, P.K., LELOUP, N., MERTENS, K., HECK, A.J.R., GROS, P. and ALLEWELL, N., 2017. Recombinant expression of the full-length ectodomain of LDL receptor-related protein 1 (LRP1) unravels phdependent conformational changes and the stoichiometry of binding with receptor-associated protein (RAP). Journal of Biological Chemistry, 292(3), pp. 912-924.
  20. EBBERINK, E.H.T.M., BOUWENS, E.A.M., BLOEM, E., BOON-SPIJKER, M., VAN DEN BIGGELAAR, M., VOORBERG, J., MEIJER, A.B. and MERTENS, K., 2017. Factor VIII/V C-domain swaps reveal discrete C-domain roles in factor VIII function and intracellular trafficking. Haematologica, 102(4), pp. 686-694.
  21. ERGEN, C., HEYMANN, F., AL RAWASHDEH, W., GREMSE, F., BARTNECK, M., PANZER, U., POLA, R., PECHAR, M., STORM, G., MOHR, N., BARZ, M., ZENTEL, R., KIESSLING, F., TRAUTWEIN, C., LAMMERS, T. and TACKE, F., 2017. Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles. Biomaterials, 114, pp. 106-120.
  22. FLIERVOET, L.A.L., NAJAFI, M., HEMBURY, M. and VERMONDEN, T., 2017. Heterofunctional Poly(ethylene glycol) (PEG) Macroinitiator Enabling Controlled Synthesis of ABC Triblock Copolymers. Macromolecules, 50(21), pp. 8390-8397.
  23. FÜLÖP, T.G., METSELAAR, J.M., STORM, G. and SZEBENI, J., 2017. The role of thromboxane A2in complement activation-related pseudoallergy. European Journal of Nanomedicine, 9(2), pp. 59-67.
  24. GHOLIZADEH, S., VISWESWARAN, G.R.R., STORM, G., HENNINK, W.E., KAMPS, J.A.A.M. and KOK, R.J., 2017. E-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cells. International journal of pharmaceutics, S0378-5173(17), 30997-3.(in press).
  25. GOH, W.J., ZOU, S., ONG, W.Y., TORTA, F., ALEXANDRA, A.F., SCHIFFELERS, R.M., STORM, G., WANG, J.-., CZARNY, B. and PASTORIN, G., 2017. Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: A Cost-Effective Alternative. Scientific Reports, 7(1) :14322,.
  26. GUAN, J., SUN, J., SUN, F., LOU, B., ZHANG, D., MASHAYEKHI, V., SADEGHI, N., STORM, G., MASTROBATTISTA, E. and HE, Z., 2017. Hypoxia-induced tumor cell resistance is overcome by synergistic GAPDH-siRNA and chemotherapy co-delivered by long-circulating and cationic-interior liposomes. Nanoscale, 9(26), pp. 9190-9201.
  27. HARE, J.I., LAMMERS, T., ASHFORD, M.B., PURI, S., STORM, G. and BARRY, S.T., 2017. Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Advanced Drug Delivery Reviews, 108, pp. 25-38.
  28. JANSEN, K., SCHUURMANS, C.C.L., JANSEN, J., MASEREEUW, R. and VERMONDEN, T., 2017. Hydrogel-based cell therapies for kidney regeneration: Current trends in biofabrication and in vivo repair. Current pharmaceutical design, 23(26), pp. 3845-3857.
  29. KALICHARAN, R.W., OUSSOREN, C., SCHOT, P., DE RIJK, E. and VROMANS, H., 2017. The contribution of the in-vivo fate of an oil depot to drug absorption. International journal of pharmaceutics, 528(1-2), pp. 595-601.
  30. KASMI, S., LOUAGE, B., NUHN, L., VERSTRAETE, G., VAN HERCK, S., VAN STEENBERGEN, M.J., VERVAET, C., HENNINK, W.E. and DE GEEST, B.G., 2017. Acrylamides with hydrolytically labile carbonate ester side chains as versatile building blocks for well-defined block copolymer micelles via RAFT polymerization. Polymer Chemistry, 8(42), pp. 6544-6557.
  31. KOCH, M., DE JONG, J.S., GLATZ, J., SYMVOULIDIS, P., LAMBERTS, L.E., ADAMS, A.L.L., KRANENDONK, M.E.G., VAN TERWISSCHA SCHELTINGA, A.G.T., AICHLER, M., JANSEN, L., DE VRIES, J., HOOGE, M.N.L.-., SCHRODER, C.P., JORRITSMA-SMIT, A., LINSSEN, M.D., DE BOER, E., VAN VEGT, B.D., NAGENGAST, W.B., ELIAS, S.G., OLIVEIRA, S., WITKAMP, A.J., MALI, W.P.T.M., WALL, E.D., GARCIA-ALLENDE, P.B., VAN DIEST, P.J., DE VRIES, E.G.E., WALCH, A., VAN DAM, G.M. and NTZIACHRISTOS, V., 2017. Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer. Cancer research, 77(3), pp. 623-631.
  32. KOOIJMAN, M., HEKKERT, M.P., VAN MEER, P.J.K., MOORS, E.H.M. and SCHELLEKENS, H., 2017. How institutional logics hamper innovation: The case of animal testing. Technological Forecasting and Social Change, 118, pp. 70-79.
  33. KORDALIVAND, N., LI, D., BEZTSINNA, N., SASTRE TORANO, J., MASTROBATTISTA, E., VAN NOSTRUM, C.F., HENNINK, W.E. and VERMONDEN, T., 2017. Polyethyleneimine coated nanogels for the intracellular delivery of RNase A for cancer therapy. Chemical Engineering Journal, (in press).
  34. LAMBERTS, L.E., KOCH, M., DE JONG, J.S., ADAMS, A.L.L., GLATZ, J., KRANENDONK, M.E.G., VAN SCHELTINGA, A.G.T.T., JANSEN, L., DE VRIES, J., LUB-DE HOOGE, M.N., SCHRÖDER, C.P., JORRITSMA-SMIT, A., LINSSEN, M.D., DE BOER, E., VAN DER VEGT, B., NAGENGAST, W.B., ELIAS, S.G., OLIVEIRA, S., WITKAMP, A.J., MALI, W.P.T.M., VAN DER WALL, E., VAN DIEST, P.J., DE VRIES, E.G.E., NTZIACHRISTOS, V. and VAN DAM, G.M., 2017. Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: A phase I feasibility study. Clinical Cancer Research, 23(11), pp. 2730-2741.
  35. LAMMERTINK, B.H.A., DECKERS, R., DERIEPPE, M., DE COCK, I., LENTACKER, I., STORM, G., MOONEN, C.T.W. and BOS, C., 2017. Dynamic Fluorescence Microscopy of Cellular Uptake of Intercalating Model Drugs by Ultrasound-Activated Microbubbles. Molecular Imaging and Biology, 19(5), pp. 683-693.
  36. LI, D., CHEN, Y., MASTROBATTISTA, E., VAN NOSTRUM, C.F., HENNINK, W.E. and VERMONDEN, T., 2017. Reduction-sensitive polymer-shell-coated nanogels for intracellular delivery of antigens. ACS Biomaterials Science and Engineering, 3(1), pp. 42-48.
  37. LI, D., VAN NOSTRUM, C.F., MASTROBATTISTA, E., VERMONDEN, T. and HENNINK, W.E., 2017. Nanogels for intracellular delivery of biotherapeutics. Journal of Controlled Release, 259, pp. 16-28.
  38. LOU, B., BEZTSINNA, N., MOUNTRICHAS, G., VAN DEN DIKKENBERG, J.B., PISPAS, S. and HENNINK, W.E., 2017. Small nanosized poly(vinyl benzyl trimethylammonium chloride) based polyplexes for siRNA delivery. International journal of pharmaceutics, 525(2), pp. 388-396.
  39. LOUAGE, B., DE WEVER, O., HENNINK, W.E. and DE GEEST, B.G., 2017. Developments and future clinical outlook of taxane nanomedicines. Journal of Controlled Release, 253, pp. 137-152.
  40. LOUAGE, B., VAN STEENBERGEN, M.J., NUHN, L., RISSEEUW, M.D.P., KARALIC, I., WINNE, J., VAN CALENBERGH, S., HENNINK, W.E. and DE GEEST, B.G., 2017. Micellar paclitaxel-initiated raft polymer conjugates with acid-sensitive behavior. ACS Macro Letters, 6(3), pp. 272-276.
  41. MARTÍN-SAAVEDRA, F., RUIZ-HERNÁNDEZ, E., ESCUDERO-DUCH, C., PRIETO, M., ARRUEBO, M., SADEGHI, N., DECKERS, R., STORM, G., HENNINK, W.E., SANTAMARÍA, J. and VILABOA, N., 2017. Lipogels responsive to near-infrared light for the triggered release of therapeutic agents. Acta Biomaterialia, 61, pp. 54-65.
  42. Mitragotri, S, Lammers, T, Bae, Y.H., Schwendeman, S., De Smedt, S., Leroux, J.C., Peer, D, Kwon, I.C., Harashima, H., Kikuchi, A., Oh, Y.K., Torchilin, V., Hennink, W., Hanes, J., and Park, K. Drug Delivery Research for the Future: Expanding the Nano Horizons and Beyond. (2017). Journal of Controlled Release 246, 183-184.
  43. MOUSER, V.H.M., ABBADESSA, A., LEVATO, R., HENNINK, W.E., VERMONDEN, T., GAWLITTA, D. and MALDA, J., 2017. Development of a thermosensitive HAMA-containing bio-ink for the fabrication of composite cartilage repair constructs. Biofabrication, 9(1),.
  44. NAYAK, T.R., WANG, H., PANT, A., ZHENG, M., JUNGINGER, H., GOH, W.J., LEE, C.K., ZOU, S., ALONSO, S., CZARNY, B., STORM, G., SOW, C.H., LEE, C. and PASTORIN, G., 2017. ZnO nano-rod devices for intradermal delivery and immunization. Nanomaterials, 7(6), 147.
  45. NOTENBOOM, K., LEUFKENS, H.G., VROMANS, H. and BOUVY, M.L., 2017. Learning from patients: Identifying design features of medicines that cause medication use problems. International journal of pharmaceutics, 517(1-2), pp. 128-134.
  46. OJHA, T., PATHAK, V., SHI, Y., HENNINK, W.E., MOONEN, C.T.W., STORM, G., KIESSLING, F. and LAMMERS, T., 2017. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. Advanced Drug Delivery Reviews, 119, pp. 44-60.
  47. O'NEILL, H.S., HERRON, C.C., HASTINGS, C.L., DECKERS, R., LOPEZ NORIEGA, A., KELLY, H.M., HENNINK, W.E., MCDONNELL, C.O., O'BRIEN, F.J., RUIZ-HERNÁNDEZ, E. and DUFFY, G.P., 2017. A stimuli responsive liposome loaded hydrogel provides flexible on-demand release of therapeutic agents. Acta Biomaterialia, 48, pp. 110-119.
  48. OUDE BLENKE, E., SLESZYNSKA, M., EVERS, M.J.W., STORM, G., MARTIN, N.I. and MASTROBATTISTA, E., 2017. Strategies for the Activation and Release of the Membranolytic Peptide Melittin from Liposomes Using Endosomal pH as a Trigger. Bioconjugate chemistry, 28(2), pp. 574-582.
  49. ÖZTÜRK AKCORA, B., STORM, G., PRAKASH, J. and BANSAL, R., 2017. Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model. Scientific Reports, 7 :44545.
  50. POLDERVAART, M.T., GOVERSEN, B., DE RUIJTER, M., ABBADESSA, A., MELCHELS, F.P.W., ÖNER, F.C., DHERT, W.J.A., VERMONDEN, T. and ALBLAS, J., 2017. 3D bioprinting of methacrylated hyaluronic acid (MeHA) hydrogel with intrinsic osteogenicity. PLoS ONE, 12(6):e0177628.
  51. RAD-MALEKSHAHI, M., FRANSEN, M.F., KRAWCZYK, M., MANSOURIAN, M., BOURAJJAJ, M., CHEN, J., OSSENDORP, F., HENNINK, W.E., MASTROBATTISTA, E. and AMIDI, M., 2017. Self-Assembling Peptide Epitopes as Novel Platform for Anticancer Vaccination. Molecular Pharmaceutics, 14(5), pp. 1482-1493.
  52. REHOR, I., VAN VREESWIJK, S., VERMONDEN, T., HENNINK, W.E., KEGEL, W.K. and ERAL, H.B., 2017. Biodegradable Microparticles for Simultaneous Detection of Counterfeit and Deteriorated Edible Products. Small, 13(39),.
  53. RITSEMA, J.A.S., HERSCHBERG, E.M.A., BORGOS, S.E., LØVMO, C., SCHMID, R., TE WELSCHER, Y.M., STORM, G. and VAN NOSTRUM, C.F., 2017. Relationship between polarities of antibiotic and polymer matrix on nanoparticle formulations based on aliphatic polyesters. International journal of pharmaceutics, S0378-5173(17)31072-31074. (in press)
  54. SABBIETI, M.G., DUBBINI, A., LAUS, F., PAGGI, E., MARCHEGIANI, A., CAPITANI, M., MARCHETTI, L., DINI, F., VERMONDEN, T., DI MARTINO, P., AGAS, D. and CENSI, R., 2017. In vivo biocompatibility of p(HPMAm-lac)-PEG hydrogels hybridized with hyaluronan. Journal of Tissue Engineering and Regenerative Medicine, 11(11), pp. 3056-3067.
  55. SADEGHI, N., DECKERS, R., OZBAKIR, B., AKTHAR, S., KOK, R.J., LAMMERS, T. and STORM, G., 2017. Influence of cholesterol inclusion on the doxorubicin release characteristics of lysolipid-based thermosensitive liposomes. International journal of pharmaceutics, S0378-5173(17)31046-31053.(in press)
  56. SANDKER, M.J., DUQUE, L.F., REDOUT, E.M., CHAN, A., QUE, I., LÖWIK, C.W.G.M., KLIJNSTRA, E.C., KOPS, N., STEENDAM, R., VAN WEEREN, R., HENNINK, W.E. and WEINANS, H., 2017. Degradation, intra-articular retention and biocompatibility of monospheres composed of [PDLLA-PEG-PDLLA]-b-PLLA multi-block copolymers. Acta Biomaterialia, 48, pp. 401-414.
  57. SCHELLEKENS, H., ALDOSARI, M., TALSMA, H. and MASTROBATTISTA, E., 2017. Making individualized drugs a reality. Nature biotechnology, 35(6), pp. 507-513.
  58. SCHNITTERT, J., KUNINTY, P.R., BYSTRY, T.F., BROCK, R., STORM, G. and PRAKASH, J., 2017. Anti-microRNA targeting using peptide-based nanocomplexes to inhibit differentiation of human pancreatic stellate cells. Nanomedicine, 12(12), pp. 1369-1384.
  59. SHI, Y., LAMMERS, T., STORM, G. and HENNINK, W.E., 2017. Physico-Chemical Strategies to Enhance Stability and Drug Retention of Polymeric Micelles for Tumor-Targeted Drug Delivery. Macromolecular Bioscience, 17(1): 1600160.
  60. SOFIAS, A.M., DUNNE, M., STORM, G. and ALLEN, C., 2017. The battle of “nano” paclitaxel. Advanced Drug Delivery Reviews, 122, pp. 20-30.
  61. STAVENUITER, F., EBBERINK, E.H.T.M., MERTENS, K. and MEIJER, A.B., 2017. Role of glycine 221 in catalytic activity of hyaluronan-binding protein 2. Journal of Biological Chemistry, 292(15), pp. 6381-6388.
  62. THIEBES, A.L., KELLY, N., SWEENEY, C.A., MCGRATH, D.J., CLAUSER, J., KURTENBACH, K., GESCHE, V.N., CHEN, W., KOK, R.J., STEINSEIFER, U., BRUZZI, M., O’BRIEN, B.J., MCHUGH, P.E., JOCKENHOEVEL, S. and CORNELISSEN, C.G., 2017. PulmoStent: In Vitro to In Vivo Evaluation of a Tissue Engineered Endobronchial Stent. Annals of Biomedical Engineering, 45(4), pp. 873-883.
  63. TUŸSÜZ, N., VAN BLOOIS, L., VAN DEN BRINK, S., BEGTHEL, H., VERSTEGEN, M.M.A., CRUZ, L.J., HUI, L., VAN DER LAAN, L.J.W., DE JONGE, J., VRIES, R., BRAAKMAN, E., MASTROBATTISTA, E., CORNELISSEN, J.J., CLEVERS, H. and TEN BERGE, D., 2017. Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells. Nature Communications, 8.
  64. Varela-Moreira, A., Shi, Y., Fens, M.H.A.M., Lammers, T., Hennink, W.E. and Schiffelers, R.M., 2017. Clinical application of polymeric micelles for the treatment of cancer. Materials Chemistry Frontiers 1, 1486-1501.
  65. VAN DEN ESHOF, B.L., HOOGENDIJK, A.J., SIMPSON, P.J., VAN ALPHEN, F.P.J., ZANIVAN, S., MERTENS, K., MEIJER, A.B. and VAN DEN BIGGELAAR, M., 2017. Paradigm of Biased PAR1 (Protease-Activated Receptor-1) Activation and Inhibition in Endothelial Cells Dissected by Phosphoproteomics. Arteriosclerosis, Thrombosis, and Vascular Biology, 37(10), pp. 1891-1902.
  66. VAN DER GEEST, T., LAVERMAN, P., GERRITS, D., WALGREEN, B., HELSEN, M.M., KLEIN, C., NAYAK, T.K., STORM, G., METSELAAR, J.M., KOENDERS, M.I. and BOERMAN, O.C., 2017. Liposomal treatment of experimental arthritis can be monitored noninvasively with a radiolabeled anti-fibroblast activation protein antibody. Journal of Nuclear Medicine, 58(1), pp. 151-155.
  67. VAN DER MEEL, R., LAMMERS, T. and HENNINK, W.E., 2017. Cancer nanomedicines: oversold or underappreciated? Expert Opinion on Drug Delivery, 14(1), pp. 1-5.
  68. VAN HEUGTEN, A.J.P., BRAAL, C.L., VERSLUIJS-HELDER, M. and VROMANS, H., 2017. The influence of cetomacrogol ointment processing on structure: A definitive screening design. European Journal of Pharmaceutical Sciences, 99, pp. 279-284.
  69. VAN HEUGTEN, A.J.P., VERSLUIJS-HELDER, M. and VROMANS, H., 2017. Elucidation of the variability in consistency of pharmacopoeia quality petrolatum. Drug development and industrial pharmacy, 43(4), pp. 595-599.
  70. VAN LITH, S.A.M., VAN DUIJNHOVEN, S.M.J., NAVIS, A.C., LEENDERS, W.P.J., DOLK, E., WENNINK, J.W.H., VAN NOSTRUM, C.F. and VAN HEST, J.C.M., 2017. Legomedicine - A Versatile Chemo-Enzymatic Approach for the Preparation of Targeted Dual-Labeled Llama Antibody-Nanoparticle Conjugates. Bioconjugate chemistry, 28(2), pp. 539-548.
  71. VAN RIET-NALES, D., SCHOBBEN, F., VROMANS, H., EGBERTS, T. and RADEMAKER, C., 2017. Child-friendly medicines. Huisarts en Wetenschap, 60(1), pp. 15-19.
  72. VAN STRATEN, D., MASHAYEKHI, V., DE BRUIJN, H.S., OLIVEIRA, S. and ROBINSON, D.J., 2017. Oncologic photodynamic therapy: Basic principles, current clinical status and future directions. Cancers, 9(2): 19.
  73. VERHOEF, J.J.F., BARENDRECHT, A.D., NICKEL, K.F., DIJKXHOORN, K., KENNE, E., LABBERTON, L., MCCARTY, O.J.T., SCHIFFELERS, R., HEIJNEN, H.F., HENDRICKX, A.P., SCHELLEKENS, H., FENS, M.H., DE MAAT, S., RENNÉ, T. and MAAS, C., 2017. Polyphosphate nanoparticles on the platelet surface trigger contact system activation. Blood, 129(12), pp. 1707-1717.
  74. VERHOEF, J.J.F., DE GROOT, A.M., VAN MOORSEL, M., RITSEMA, J., BEZTSINNA, N., MAAS, C. and SCHELLEKENS, H., 2017. Iron nanomedicines induce Toll-like receptor activation, cytokine production and complement activation. Biomaterials, 119, pp. 68-77.
  75. WENNINK, J.W.H., LIU, Y., MÄKINEN, P.I., SETARO, F., DE LA ESCOSURA, A., BOURAJJAJ, M., LAPPALAINEN, J.P., HOLAPPA, L.P., VAN DEN DIKKENBERG, J.B., AL FARTOUSI, M., TROHOPOULOS, P.N., YLÄ-HERTTUALA, S., TORRES, T., HENNINK, W.E. and VAN NOSTRUM, C.F., 2017. Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases. European Journal of Pharmaceutical Sciences, 107, pp. 112-125.
  76. XENAKI, K.T., OLIVEIRA, S. and VAN BERGEN EN HENEGOUWEN, P.M.P., 2017. Antibody or antibody fragments: Implications for molecular imaging and targeted therapy of solid tumors. Frontiers in Immunology, 8: 1287.
  77. ZOU, Y., WEI, Y., WANG, G., MENG, F., GAO, M., STORM, G. and ZHONG, Z., 2017. Nanopolymersomes with an Ultrahigh Iodine Content for High-Performance X-Ray Computed Tomography Imaging In Vivo. Advanced Materials, 29(10):1603997.